The DOI matches its Crossref record; 108 of the 110 references it cites were found in a registry or an index.
Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment
Open accessAbstract
Radiotherapy is an essential component of the treatment regimens for many cancer patients. Despite recent technological advancements to improve dose delivery techniques, the dose escalation required to enhance tumor control is limited due to the inevitable toxicity to the surrounding healthy tissue. Therefore, the local enhancement of dosing in tumor sites can provide the necessary means to improve the treatment modality. In recent years, the emergence of nanotechnology has facilitated a unique opportunity to increase the efficacy of radiotherapy treatment. The application of high-atomic-number (Z) nanoparticles (NPs) can augment the effects of radiotherapy by increasing the sensitivity of cells to radiation. High-Z NPs can inherently act as radiosensitizers as well as serve as targeted delivery vehicles for radiosensitizing agents. In this work, the therapeutic benefits of high-Z NPs as radiosensitizers, such as their tumor-targeting capabilities and their mechanisms of sensitization, are discussed. Preclinical data supporting their application in radiotherapy treatment as well as the status of their clinical translation will be presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 4 Enhanced cellular uptake of nanoparticles via targeting moieties. (A) Dark-field imaging of gold nanoparticles (yellow color) in MDA-MB-231 cells incubated with PBS (control), anti-CXCR4 functionalized GNPs (cGNP), or PEGylated GNPs (pGNP). Cell nuclei are stained in blue. (B) Cell uptake of rhodium-labeled folate functionalized AuNPs (Rho-FAx-AuNPs) by KB (overexpression of folate receptors) and MCF-7 (low expression of folate receptors) cells. AuNPs were functionalized with various surface concentrations of folate. Statistical significance was calculated versus non-targeted particles (Rho-Fa0 -AuNPs): **** p < 0.0001, ns nonsignificant. (C) Effects of PEG and RGD on the cellular accumulation of GNPs. Reproduced with permission from open access Creative Common license [16,28,30].](https://figures.cochat.ai/paper-figures/dde10b6e00ff4b3b81bf7c061c760d0c/application-of-high-z-nanoparticles-to-enhance-current-radiotherapy-treatment-figure-4.jpg)
![Figure 6 Radiosensitization due to high-Z nanoparticles. (A) Normalized tumor volumes of MDA-MB-231 xenograft tumor-bearing mice post treatment with cGNP alone, radiation (10 Gy single dose) alone, pGNP + radiation (RT), or cGNP + RT (B) Survival fraction curves of CHO-K1 cells treated with AuNPs and irradiated at various doses with a 200 MeV proton beam. (C) Kaplan–Meier survival curves for U251 tumor-bearing mice treated with AuNPs or AgNPs with or without ionizing radiation (IR). Mice were irradiated with a single dose of 8 Gy with a 6 MV X-ray beam. Mice were treated with AgNPs at the same molar concentration (mol-AgNPs) or mass concentration (mas-AgNPs) as AuNPs. (D) Apoptosis of U251 cells after treatment with AgNPs or AuNPs combined with a radiation dose of 6 Gy. * p < 0.05, *** p < 0.001 compared with the control group. ## p < 0.01, ### p < 0.001 compared with the corresponding AuNPs-treated group (E) Tumor volume growth curves after treatment with HA-Gd2O3 NPs and radiation (R + HA-Gd). Mice were administered 3 fractions of 3 Gy with a 6 MeV beam over a 7-day period for a total of 9 Gy. Reproduced with permission from open access Creative Common license [28,74,75,76].](https://figures.cochat.ai/paper-figures/723ae60ee8f4440b9d1a9dc94f46bffc/application-of-high-z-nanoparticles-to-enhance-current-radiotherapy-treatment-figure-6.jpg)
![Figure 7 Dual radiosensitization through docetaxel-loaded gold nanoparticles. (A) Normalized tumor growth curves of 22RV1 xenograft tumor-bearing mice after irradiation of 6 Gy with 6 MeV electron beam. (B) Concentration of Au in 22RV1 xenograft tumor post-injection with Au-DUPA NPs or Au@DTX-DUPA NPs. (C) Cell cycle analysis of 22RV1 cells after treatment with Au-DUPA NPs, free DTX, or Au@DTX-DUPA NPs. (D) Ki67 staining assay of tumors 15 days post treatment to indicate proliferative capacity. * p < 0.05, ** p < 0.01. Reproduced with permission from open access Creative Common license [90].](https://figures.cochat.ai/paper-figures/f88723c85b6f4735b1cedba359d7a93a/application-of-high-z-nanoparticles-to-enhance-current-radiotherapy-treatment-figure-7.jpg)

![Figure 2 Passive targeting of NPs. (A) The poor structural integrity and lymphatic drainage of the tumor vasculature system result in the passive preferential accumulation of NPs in tumors compared with normal tissue. This is referred to as the EPR effect. (Created using Biorender.com). (B) Hyperspectral imaging demonstrating blood vessels facilitating the delivery of GNPs to the surrounding mice tumor tissue. Reproduced with permission from open access Creative Common license [16].](https://figures.cochat.ai/paper-figures/3d675a74c5144ed58de4aeace5c9799c/application-of-high-z-nanoparticles-to-enhance-current-radiotherapy-treatment-figure-2.jpg)
![Figure 3 Active targeting of NPs. (A) Many cancer cells overexpress various surface receptors in comparison with normal cells. The surface of NPs can be strategically modified with corresponding ligands to specifically bind to these receptors, increasing their uptake in cancer cells. (Created using Biorender.com). (B) Accumulation of cancer targeting GNPs in cancer cells versus normal fibroblasts. Cancer cells demonstrate greater accumulation of GNPs compared with normal fibroblasts due to their overexpression of targeted receptors. Top panel: hyperspectral imaging of GNPs. Bottom panel: confocal imaging of GNPs (red) and microtubules (green). Reproduced with permission from open access Creative Common license [20].](https://figures.cochat.ai/paper-figures/4533e32089c14bafa5b1686c6f3c3cfb/application-of-high-z-nanoparticles-to-enhance-current-radiotherapy-treatment-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nanoparticle-mediated radiosensitization has emerged as a promising strategy to enhance the therapeutic index of irradiation by combining physical dose amplification with biological, microenvironmental, and immunological modulation.”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These systems primarily function through physical interactions with ionizing radiation. Owing to their high electron density, they increase local X-ray absorption and promote the generation of secondary electrons, including photoelectrons and Auger electrons, resulting in amplified energy deposition within irradiated tumor tissues [10,84,85,86].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“High-Z nanomaterials amplify these effects by increasing local energy deposition and secondary electron generation, thereby enhancing intracellular ROS production and DNA damage [10,85,86,88].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“High-Z nanoparticles enhance ROS generation by increasing local energy deposition and secondary electron emission, thereby amplifying free radical formation and oxidative stress following irradiation [9,10,86,88,102,103].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“In general, materials with higher atomic numbers exhibit greater photoelectric interaction probabilities and therefore greater potential for secondary electron generation and local dose enhancement, particularly at kilovoltage photon energies [9,10,84,85,86].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879 · cited 1×
“It uptake [92].”
Self-citationPEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523 · cited 2×
“…molecules, like polyethylene glycol This is commonly achieved through the addition of ‘stealth’ molecules, like polyethylene glycol (PEG), to the surface of NPs, which enables them to evade clearance from the reticuloendothelial system, preventing opsonization and subsequent phagocytosis [17,18].”
BackgroundEffect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431 · cited 2×
“…molecules, like polyethylene glycol This is commonly achieved through the addition of ‘stealth’ molecules, like polyethylene glycol (PEG), to the surface of NPs, which enables them to evade clearance from the reticuloendothelial system, preventing opsonization and subsequent phagocytosis [17,18].”
BackgroundTargeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172 · cited 1×
“For example, the tumor microenvironment can become hypoxic, increasing the resistance of tumors to radiotherapy treatment [6].”
BackgroundPignon, J.-P., Maître, A. L., Maillard, E., & Bourhis, J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.04.014 · Cited by 3,069 · cited 1×
“…is a strategy that is applied in certain cancer treatment regimens, aiming to capitalize on the complementary mechanisms of both treatments to achieve better tumor control and curative rates, where studies have demonstrated increased loco-regional control and overall survival of patients [79–82].”
BackgroundVolumetric modulated arc therapy: IMRT in a single gantry arc
Otto, K. (2008) · Medical Physics · doi:10.1118/1.2818738 · Cited by 1,882
Size‐Dependent Cytotoxicity of Gold Nanoparticles
Pan, Y., Neuss, S., Leifert, A., Fischler, M., Wen, F., Simon, U., Schmid, G., Brandau, W., & Jahnen‐Dechent, W. (2007) · Small · doi:10.1002/smll.200700378 · Cited by 1,878
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846 · cited 1×
“…accumulation stems from the chaotic nature of the vasculature system present within the tumor microenvironment that forms as a result of angiogenesis, a hallmark of cancer. slow venous return characterized in tumors impede the removal of these small molecules, promoting their retention [14,15].”
BackgroundCarlson, C., Hussain, S. M., Schrand, A. M., K. Braydich-Stolle, L., Hess, K. L., Jones, R. L., & Schlager, J. J. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp712087m · Cited by 1,814
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689 · cited 1×
“…often has structural The EPR e ff ect is a phenomenon in which small molecules and particles tend to preferentially accumulate within tumor sites compared with normal tissue. abnormalities, consisting of improper endothelial junctions that permit the seepage of small molecules into tumors [13].”
Background
Cited by
Clinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics
Kobzev, D., Kulyk, O., Barmin, R. A., Tatarets, A. L., Pallares, R. M., Kiessling, F. M., Lammers, T., & Peña, Q. (2026) · Chemical Society Reviews · doi:10.1039/d6cs00165c · Cited by 32
Gunaseelan, N., Saha, P., Maher, N., & Pan, D. (2024) · ACS Nano · doi:10.1021/acsnano.4c11724 · Cited by 17
The physicochemical and biochemical mechanisms of porphyrinoid-mediated radiodynamic therapy
Leo, S., Gutierrez, N. M. C., Bulin, A., Coll, J., Sancey, L., Habermeyer, B., & Broekgaarden, M. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117861 · Cited by 13
Chemical mechanism in gold nanoparticles radiosensitization: A Monte Carlo simulation study
Antunes, J., Rabus, H., Mendes, F., Paulo, A., & Sampaio, J. M. (2025) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2025.112637 · Cited by 13
Ghaznavi, H., Rezaee, M., Reynoso, F. J., & Darafsheh, A. (2025) · Journal of Physics D Applied Physics · doi:10.1088/1361-6463/ae0e2d · Cited by 15
Metadata
- Authors
- Jackson, N., Cecchi, D., Beckham, W., & Chithrani, D. B.
- Affiliations
- University of Victoria (CA)
- University of British Columbia (CA)
- Corresponding author
- Chithrani, Devika B.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2024-05-22
- Volume
- 29
- Issue
- 11
- Pages
- 2438
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC11173748
- OpenAlex
- W4398207790
- Cited by
- 52
- References
- 110
- Citations by year
- 2026: 28 · 2025: 22 · 2024: 2
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- cIRcle (University of British Columbia) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- UVic’s Research and Learning Repository (University of Victoria) (submittedVersion, cc-by)
- Open Collections
- Funders
- Nanomedicines Innovation Network (2021-RES-SI-05, RGPIN-2017-04501, CIHR PJT-399879)
- Natural Sciences and Engineering Research Council (2021-RES-SI-05, RGPIN-2017-04501, CIHR PJT-399879)
- Canadian Institute for Health Research (2021-RES-SI-05, RGPIN-2017-04501, CIHR PJT-399879)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- high-Z nanoparticles, radiosensitizers, radiotherapy, tumor targeting, radiosensitivity, targeted drug delivery, dose escalation, radiation toxicity, clinical translation
- MeSH terms
- Animals, Humans, Neoplasms, Radiation-Sensitizing Agents, Radiotherapy, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment. https://app.cochat.ai/papers/10.3390/molecules29112438
- The paper
- Jackson, N., Cecchi, D., Beckham, W., & Chithrani, D. B. (2024). Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment. Molecules. https://doi.org/10.3390/molecules29112438
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.